EDTA chelation therapy in chronic degenerative disease

Area of Science:

• Cardiovascular Medicine
• Geriatrics
• Integrative Medicine

Background:

• Chronic degenerative and age-associated diseases pose significant health challenges.
• Current treatments for conditions like ischemic heart disease and peripheral vascular disease have limitations.
• EDTA chelation therapy has been controversially viewed, necessitating further investigation.

Purpose of the Study:

• To retrospectively analyze the efficacy of di-sodium magnesium EDTA chelation therapy.
• To re-evaluate the therapeutic potential of EDTA chelation therapy for various chronic conditions.
• To assess the improvement rates in patients with vascular and degenerative diseases treated with EDTA chelation therapy.

Main Methods:

• Retrospective analysis of treatment outcomes in 2870 patients.
• Standardized qualitative criteria were used to assess patient improvement.
• Data collected on patients with ischemic heart disease, peripheral vascular disease, cerebrovascular diseases, scleroderma, and geriatric symptomatology.

Main Results:

• Significant improvement observed in ischemic heart disease (76.89% marked, 16.56% good).
• High efficacy in peripheral vascular disease and intermittent claudication (91% marked, 7.6% good).
• Positive outcomes in cerebrovascular diseases (24% marked, 30% good) and geriatric symptoms (75% marked).

Conclusions:

• EDTA chelation therapy demonstrates considerable efficacy in improving symptoms of various chronic degenerative and vascular diseases.
• The study suggests a potential
• tomato effect
• where a beneficial therapy is disregarded by the medical community.
• Renewed investigation and FDA-approved studies are recommended to validate EDTA chelation therapy, particularly for peripheral vascular disease.